- ICH GCP
- Registro de ensaios clínicos dos EUA
- Ensaio Clínico NCT01007422
Opioids Titration in Hospice Patients
Opioid Titration In the Hospice Setting: Barriers Assessment and Modification of the Model Order Sheet and Protocol Stage 2, Part B
RATIONALE: Opioids lessen pain caused by cancer. Titration of opioids in the hospice setting is suboptimal due to numerous barriers. Order sets may help to provide timely and effective medical and pharmaceutical intervention.
PURPOSE: The purpose of this study was to identify barriers to good pain control in the hospice setting and to develop an order set that would safely address these barriers.
Visão geral do estudo
Status
Condições
Intervenção / Tratamento
- Outro: revisão de prontuário
- Outro: administração de pesquisa
- Procedimento: avaliação e atendimento psicossocial
- Comportamental: intervenção por telefone
- Procedimento: terapia da dor
- Procedimento: tratamento/gerenciamento em fim de vida
- Outro: intervenção de comunicação
- Outro: intervention by caregiver
Descrição detalhada
Objective 1:
To assess barriers to pain control in the hospice setting.
Using a mixed methods approach, key stakeholders including physicians, nurses, patients and caregivers were queried about pain control in the hospice setting, barriers to pain control and the desirability of an order set to address this issue.
Objective 2:
To develop and conduct pilot testing of an order set designed to improve pain control in the hospice setting.
An opioid titration order sheet based on our previous R0-1 was modified based on the information derived from the interviews and questionnaires completed by the physicians, nurses, patients and caregivers.
A cohort of 20 patients were enrolled on the first phase of the pilot study in order to test the modified pain assessment form and the feasibility administration of the study materials to be completed by the patient and caregiver. Forms are as follows:
- Patient assessment: At baseline, patients provide demographic data and complete the Pain Assessment Form and the Pain Communication Survey. The pain assessment form addresses average pain, worst pain, pain relief, hours in pain, pain-related distress, and barriers to pain control. Patients are asked to rate pain control. Patients also complete the Pain Communication Survey to assess how they communicate with healthcare providers about their pain. After the baseline assessment is completed, patients complete the Pain Assessment form on a daily basis. Pain is also assessed by the research nurse at least 3 times weekly (1 home visit* and 2 telephone interviews). Patients are followed until the time of death.
NOTE: *If a patient is hospitalized or transferred to the inpatient hospice facility, the patient interview will take place there.
- Caregiver assessment: At baseline, caregivers complete a demographic survey, a Pain Assessment Form, the Pain Communication Survey, Caregiver Self-Efficacy in Pain Management Scale (CSEPMS), Caregiver Pain Management Questionnaire (CPMQ), and the Stressful Caregiver Adult Reactions to Experiences of Dying (SCARED). Caregivers are then interviewed by the study nurse using the Pain Assessment Form as a guideline to obtain more detailed information about adequacy of the patient's pain control, side effects of medication, barriers to pain control, and caregiver concerns and burden. Follow-up data from caregivers is obtained through completion of CSEPMS, CPMQ, and SCARED questionnaires and their assessment of patient's pain form at the end of weeks 1, 2, and 3.
- Chart review: A research nurse conducts a chart review after patient's death. Cancer and cancer-related treatment data is obtained and documentation about pain management is recorded. From the time of study entry, all staff notes are reviewed to document pain assessment, calls to physician or other support personnel (including pharmacy calls), identified barriers to pain control, and treatment modifications (including medications to treat side effects).
After 20 patients, it was deemed not feasible to complete the study forms and to recruit adequately for the trial. The study was suspended.
Tipo de estudo
Critérios de participação
Critérios de elegibilidade
Idades elegíveis para estudo
Aceita Voluntários Saudáveis
Gêneros Elegíveis para o Estudo
Método de amostragem
População do estudo
Descrição
DISEASE CHARACTERISTICS:
Meets 1 of the following criteria:
Outpatient at the Alive Hospice in the State of Tennessee
- Diagnosed with carcinoma
- Pain requiring fixed-dose opioids
Caregiver for an Alive Hospice patient
- Any caregiver who is identified by the patient is eligible
PATIENT CHARACTERISTICS:
- Not pregnant or nursing
- Able to speak/comprehend English
- Lives within a 60-mile radius of Alive Hospice
PRIOR CONCURRENT THERAPY:
- See Disease Characteristics
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
Coortes e Intervenções
Grupo / Coorte |
Intervenção / Tratamento |
|---|---|
|
Supportive Care
|
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
To obtain determine the safety and feasibility of an opioid titration order sheet in the hospice setting.
Prazo: at 4 weeks
|
Pain assessments will be completed at baseline and daily for 4 weeks.
Survey instruments will be completed at the end of weeks 1, 2, and 3.
|
at 4 weeks
|
Colaboradores e Investigadores
Patrocinador
Colaboradores
Investigadores
- Investigador principal: Barbara A. Murphy, MD, Vanderbilt-Ingram Cancer Center
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo
Conclusão Primária (Real)
Conclusão do estudo (Real)
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Estimativa)
Atualizações de registro de estudo
Última Atualização Postada (Estimativa)
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Mais Informações
Termos relacionados a este estudo
Palavras-chave
Outros números de identificação do estudo
- VICC SUPP 0822
- P30CA068485 (Concessão/Contrato do NIH dos EUA)
- VU-VICC-SUPP-0822
- VU-VICC-IRB-IRB-080370
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .
Ensaios clínicos em revisão de prontuário
-
Schön Klinik Berchtesgadener LandConcluídoDoença de obstrução pulmonar crônicaAlemanha
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityRecrutamentoRadioterapia desescalada; Câncer de Cabeça e PescoçoChina
-
Schön Klinik Berchtesgadener LandConcluídoDoença de obstrução pulmonar crônicaAlemanha
-
Soterix MedicalGeorgetown University; National Institute of Neurological Disorders and Stroke... e outros colaboradoresConcluído
-
Soterix MedicalNYU Langone HealthConcluídoDepressão resistente ao tratamento | Depressão UnipolarEstados Unidos
-
Indiana UniversityAinda não está recrutando
-
Matthew EagletonMassachusetts General HospitalInscrevendo-se por conviteDissecção aórtica | Dissecção da Aorta Ascendente | Aneurisma da Aorta Toracoabdominal | Aneurismas da Aorta Torácica | Dissecção, Aneurisma | Aneurisma da Aorta Ascendente | Arco aórtico; Aneurisma Dissecante | Aneurisma da Artéria Renal | Aneurisma da Artéria Mesentérica SuperiorEstados Unidos
-
Abbott Medical DevicesConcluído
-
Abbott Medical DevicesRescindido
-
Cordio MedicalConcluído